This website uses cookies to improve functionality and performance. With a click on the OK button you are giving implied consent to the use of cookies on this website.
More information
Login Environment Pharma

Highest quality standards - worldwide

Within the SYNLAB Pharma all our sites operate under a harmonised Quality Management system, designed to comply with the most stringent requirements of the pharmaceutical industry.

In addition to our own comprehensive quality procedures, we undergo regular audits from customers and regulatory authorities including, DAkkS, FDA, OECD, Swiss Medic and UKAS. This ensures an on-going review of all methods and procedures and results in a continuous improvement in quality processes.

Specialised facilities work according to GMP, GLP, GCLP or GCP, depending upon the quality standards required for your project.

SYNLAB performs periodic audits of all network laboratories involved in clinical trials worldwide to monitor and maintain the highest quality standards and ensure data comparability.

Contact us


View All
Fellbach wird neuer Laborstandort
Nach zweijähriger Planungs- und Umbauphase entstand in Fellbach das neue Labor der SYNLAB Analytics & Services Germany GmbH.
Aug 10, 2018 Continue
Determination of the Impurity N-Nitroso dimethyl amine (NDMA) in Drug Substances with GC-MS

Due to contamination of a drug substance with the potential mutagenic substance N-Nitroso dimethyl amine (NDMA) a massive recall campaign was initiated for the related drug products. SYNLAB Pharma offers a GC-MS test for testing the absence of NDMA in drug substances and drug products.

Please contact our experts.

Jul 13, 2018 | Pharma Continue
New Services in Regulatory Compliance for Biologics

With immediate effect, SYNLAB Pharma provides a broad support in the field of Regulatory Compliance of Biologics development. With this new services we support specifically start-ups, small to medium sized biotech companies, which require professional consultancy and project execution in regulatory project design.

For further questions, please contact:

Jun 18, 2018 | Pharma Continue
View All